Barnaby Page, Author at CannIntelligence

Tamarind Intelligence podcast: what’s next for e-cigarette regulation?

Written by Barnaby Page || 24th February 2025 || Podcasts |

Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond ...

Could Switzerland be the first in Europe to fully legalise recreational cannabis?

Written by Barnaby Page || 20th February 2025 || Blogs , News analysis |

Though it’s still early days, Switzerland could become the first European country to wholeheartedly legalise recreational cannabis, though that doesn’t mean that progress in Europe is speeding up ...

Tamarind Intelligence podcast: Global insights into novel nicotine regulation

Written by Barnaby Page || 14th February 2025 || Podcasts |

Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine...

New opportunities emerge in European cannabis markets

Written by Barnaby Page || 10th December 2024 || Press releases |

FOR IMMEDIATE RELEASE Business opportunities start to appear in European legal cannabis markets Recent initiatives on legalising cannabis in four European countries have put the spotlight on the commercial potential of the cannabis market. Germany, Malta, the Netherlands...

Tamarind Intelligence podcast: A look into the illicit vape market

Written by Barnaby Page || 16th October 2024 || Podcasts |

Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette...

Why US DEA decision does not mean the end for cannabinoids

Written by Barnaby Page || 27th February 2023 || Press releases |

FOR IMMEDIATE RELEASE Why US DEA decision does not mean the end for cannabinoids The US intoxicating hemp-derived cannabinoid (IHDC) market will not be ended by clarification from authorities saying delta-8 THC-O and delta-9 THC-O are illegal. Multiple...

Lack of quality science on cannabis and pain leaves room for fake news and myth

Written by Barnaby Page || 16th June 2022 || Blogs , News analysis |

“It’s a myth that cannabis relieves pain,” declared the Daily Mail. But that is not what the study it was reporting said at all ...

The common sense of CBD science, and why it doesn’t always come to the fore

Written by Barnaby Page || 21st April 2022 || Blogs , News analysis |

Is the current system of peer-reviewed journal publication the best way to get the best science on CBD and cannabis? There could be another way ...

Unfounded claims on cancer and COVID attract warning letters from US FDA

Written by Barnaby Page || 23rd December 2020 || News analysis |

Claims that CBD could help shrink tumours were among those censured by the US Food and Drug Administration (FDA) in its latest round of warning letters to the industry ...

So this is Brexit – but what does it mean for CBD trade, now or later?

Written by Barnaby Page || 3rd February 2020 || News analysis |

As the UK exits Europe and enters its 11-month period of transition, what does Brexit actually mean for cross-Channel relationships, and for the CBD industry in particular? ...

Boris’s Brexit: what it could mean for the UK CBD industry

Written by Barnaby Page || 16th December 2019 || News analysis |

Boris Johnson’s landslide victory in the British general election means Brexit will almost certainly take place early in 2020. But will the strenthening of the Conservative grip on power have any direct impact on CBD? ...

FDA cracks down again on health claims, but seems receptive to CBD

Written by Barnaby Page || 26th November 2019 || News analysis |

Scrutiny of the CBD market appears to be growing at the US Food and Drug Administration (FDA), which this week reprimanded a further 15 companies for selling CBD products as drugs and also updated its advice to consumers...

CBD-based epilepsy drug Epidyolex gets the green light from Europe

Written by Barnaby Page || 23rd September 2019 || News analysis |

Epidyolex, the CBD-based medicine used to treat rare forms of epilepsy, has been approved by the European Medicines Agency (EMA) ...

Car drivers, stressed execs are among latest targets for CBD firms

Written by Barnaby Page || 1st April 2019 || News analysis |

CBD-infused auto fuel and an inhalable “cannabidiol homologue” are among the latest products launched by companies from outside the CBD sector keen to leverage its paradigm...

Berkeley team hold out hope for cannabinoids synthesised from yeast

Written by Barnaby Page || 14th March 2019 || News analysis |

Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley ...

Science review sees promise and problems in medical use of CBD

Written by Barnaby Page || 19th February 2019 || News analysis |

CBD shows promise for treating some medical conditions but the potential for interactions with other drugs is a cause for concern, as is poor quality control, according to a recent review of science in the field ...

WHO recommends removing CBD from world narcotics schedules

Written by Barnaby Page || 18th February 2019 || News analysis |

CBD is likely to be removed from the scope of the most significant international treaty on drug control, following a favourable report by the World Health Organization (WHO), which also recommends downgrading cannabis ...

Where in the world are the countries most likely to legalise cannabis?

Written by Barnaby Page || 17th January 2019 || News analysis |

Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis ...

We still regulate foods and health claims, FDA reminds US CBD industry

Written by Barnaby Page || 23rd December 2018 || News analysis |

Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned ...

Austria confirms ban on use of CBD in cosmetics

Written by Barnaby Page || 23rd December 2018 || News analysis |

The use of any cannabis extract in cosmetics is forbidden in Austria, authorities have recently confirmed ...

CBD could hinder potential of cannabis to treat glaucoma, study warns

Written by Barnaby Page || 20th December 2018 || News analysis |

The presence of CBD could render cannabis useless as a treatment for glaucoma, new research warns. Long-term use of the substance may even worsen one of the main risk factors for the eye disease ...

Equilibrium to add CBD to recovery shots; new CBD beer hits shelves

Written by Barnaby Page || 30th November 2018 || News analysis |

British detox products supplier Equilibrium Labs is to add CBD to its Sober Up shots next year, in a move that could benefit those with foggy heads thanks to a new CBD beer also hitting shelves. A CBD-infused version...

CBD treatments on the way as FDA grants 20th ‘orphan drug’ designation

Written by Barnaby Page || 14th November 2018 || News analysis |

The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD ...

All CBD products for animals will be treated in the UK as medicine

Written by Barnaby Page || 14th November 2018 || News analysis |

The UK’s Veterinary Medicines Directorate (VMD) has told CBD-Intel that even a product not normally considered a medicine, such as a pet food or livestock feed, will be treated as a pharmaceutical if it contains CBD ...

Don’t judge cannabis by THC/CBD content alone, say scientists

Written by Barnaby Page || 1st November 2018 || News analysis |

Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say ...

Day One for Canada – the first step into a brave new world

Written by Barnaby Page || 17th October 2018 || News analysis |

Canada’s cannabis age has officially dawned, with some CBD products as well as the plant itself becoming legal for retail and personal possession ...

CBD medicines for animals will need UK government approval

Written by Barnaby Page || 26th September 2018 || News analysis |

CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided they fall under the definition of veterinary medicines ...

Canadians plant the seeds of industry growth across Europe

Written by Barnaby Page || 13th September 2018 || News analysis |

Companies from Canada’s large cannabis sector are continuing to invest in central and eastern Europe ...

Plan to create micro-organisms that will make cannabinoids in lab

Written by Barnaby Page || 12th September 2018 || News analysis |

Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms in a partnership between a Canadian and a US company ...

Epilepsy research charity warns against unlicensed CBD products

Written by Barnaby Page || 12th September 2018 || News analysis |

A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence ...

CBD ‘may reduce temptation’ for quitters to pick up a cigarette

Written by Barnaby Page || 21st May 2018 || News analysis |

Cannabidiol (CBD) could be helpful in smoking cessation, but the area is little researched and more work is required, says a London scientist who will soon publish a paper on the topic ...

LATEST ALERTS

Written by Barnaby Page || 24th February 2025 || Podcasts |

Written by Barnaby Page || 20th February 2025 || Blogs , News analysis |

Written by Barnaby Page || 14th February 2025 || Podcasts |

Written by Barnaby Page || 10th December 2024 || Press releases |

Written by Barnaby Page || 16th October 2024 || Podcasts |

Written by Barnaby Page || 27th February 2023 || Press releases |

Written by Barnaby Page || 16th June 2022 || Blogs , News analysis |

Written by Barnaby Page || 21st April 2022 || Blogs , News analysis |

Written by Barnaby Page || 23rd December 2020 || News analysis |

Written by Barnaby Page || 3rd February 2020 || News analysis |

Written by Barnaby Page || 16th December 2019 || News analysis |

Written by Barnaby Page || 26th November 2019 || News analysis |

Written by Barnaby Page || 23rd September 2019 || News analysis |

Written by Barnaby Page || 1st April 2019 || News analysis |

Written by Barnaby Page || 14th March 2019 || News analysis |

Written by Barnaby Page || 19th February 2019 || News analysis |

Written by Barnaby Page || 18th February 2019 || News analysis |

Written by Barnaby Page || 17th January 2019 || News analysis |

Written by Barnaby Page || 23rd December 2018 || News analysis |

Written by Barnaby Page || 23rd December 2018 || News analysis |

Written by Barnaby Page || 20th December 2018 || News analysis |

Written by Barnaby Page || 30th November 2018 || News analysis |

Written by Barnaby Page || 14th November 2018 || News analysis |

Written by Barnaby Page || 14th November 2018 || News analysis |

Written by Barnaby Page || 1st November 2018 || News analysis |

Written by Barnaby Page || 17th October 2018 || News analysis |

Written by Barnaby Page || 26th September 2018 || News analysis |

Written by Barnaby Page || 13th September 2018 || News analysis |

Written by Barnaby Page || 12th September 2018 || News analysis |

Written by Barnaby Page || 12th September 2018 || News analysis |

Written by Barnaby Page || 21st May 2018 || News analysis |

Written by Barnaby Page || 22nd April 2015 || News analysis |

Sign up to our newsletter

Start your FREE trial